Who owns SEELOS THERAPEUTICS INC CLASS EQUITY?
- CUSIP Number: 81577f307
Tip: Access positions for across all investors
Analyze quarterly positions in Seelos Therapeutics Inc Class Equity with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seelos Therapeutics Inc Class Equity stock
Who bought or sold SEELOS THERAPEUTICS INC CLASS EQUITY this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AdvisorShares Investments | 90k | $56k | 100% | Jun 2024 |
|
| Morgan Stanley | 22k | $13k | 100% | Jun 2024 |
|
| BlackRock | 7.0k | $4.2k | 100% | Jun 2024 |
|
| Tower Research Capital | 3.9k | $2.3k | 100% | Jun 2024 |
|
| Vermillion & White Wealth Management Group | 123.00 | $73.000500 | 100% | Jun 2024 |
|
Who sold out of Seelos Therapeutics Inc Class Equity?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wealth Effects | Jun 2024 | 54k | $32k |
| Modera Wealth Management | Jun 2024 | 21k | $13k |
| Geode Capital Management | Jun 2024 | 13k | $7.6k |
| Carmichael Hill & Associates | Jun 2024 | 1.0k | $597.000000 |
| Jpmorgan Chase & Co | Jun 2024 | 501.00 | $501.000000 |
| Bank of America Corporation | Jun 2024 | 472.00 | $282.020000 |
| Group One Trading | Jun 2024 | 216.00 | $128.995200 |